Collaboration Leads To Early Detection When The Cancer Is Easier To Treat

Collaborating To Achieve Excellence

Pancreatic Cancer Medical Advisory Council

We are proud to introduce our new Scientific Research and Medical Advisory Council comprised of world-renowned pancreatic cancer scientists, oncology researchers, surgeons, and clinical trial lead investigators. They are elite global leaders specializing in pancreatic cancer and accomplished leadership members at their respective hospitals and medical institutions.

Each institution features highly qualified second opinions to pancreatic cancer patients to confirm their diagnosis and recommend treatment plans based on individual bio-markers. Each institution is strategically located in regions to provide access convenience for treatment and participation in clinical trials.

The synergy of collaboration enables the foundation to create greater levels of public awareness of pancreatic cancer that emphasizes the vital importance of individual vigilance and self-advocacy leading to more early detection when pancreatic cancer is more treatable and curable.

Daniel Von Hoff, MD, FACP

TGen Executive Vice President
Molecular Medicine Division

Douglas B. Evans, MD, FACS

Chair of Department of Surgery Medical
College of Wisconsin

Erkut Borazanci, MD

Leader of The Pancreatic Cancer
Detection Consortium HonorHealth
Research Institute

Susan Tsai, MD, MHS, FACS

Chief of Surgical Oncology
Ohio State James Cancer Hospital

Peter Hosein. MD

Sylvester Comprehensive Cancer Center
University of Miami Health

Jen Jen Yeh, MD

North Carolina School of Medicine
Division of Surgical Oncology